2. Neurological Disease

Neurological Disease

Neurological Disease

Related Products

PDF 88.0 MB

A range of neurological disorders, including epilepsy and dystonia, may involve dysfunctional intracortical inhibition, and may respond to treatments that modify it. Parkinson’s is a neurodegenerative disease characterized by increased activity of GABA in basal ganglia and the loss of dopamine in nigrostriatum, associated with rigidity, resting tremor, gait with accelerating steps, and fixed inexpressive face. Neurological deficits, along with neuromuscular involvement, are characteristic of mitochondrial disease, and these symptoms can have a dramatic impact on patient quality of life. Neurological features may be manifold, ranging from neural deafness, ataxia, peripheral neuropathy, migraine, seizures, stroke‐like episodes and dementia and depend on the part of the nervous system affected.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-153416
    QR-0217 1027786-12-4 98.47%
    QR-0217 is a potent Aβ1-40 aggregation inhibitor with an IC50 value of 7.5 µM. QR-0217 inhibits α-synuclein aggregation. QR-0217 reduces memory impairments caused by Aβ neurotoxicity.
    QR-0217
  • HY-153417
    Anti-amyloid agent-1 1396778-73-6 99.03%
    Anti-amyloid agent-1 (ex1140) is a potent anti-amyloid compound and inhibits amyloid aggregation, provides a useful method for amyloidosis research.
    Anti-amyloid agent-1
  • HY-153433
    Serine Hydrolase inhibitor-21 366448-34-2 99.71%
    Serine Hydrolase inhibitor-21 (compound 8), a pyridine, is a serine hydrolase inhibitor with a Ki of 429 nM for BuChE. Serine Hydrolase inhibitor-21 has the potential for Alzheimer's disease research.
    Serine Hydrolase inhibitor-21
  • HY-153463
    Diosuxentan 2305865-93-2 98%
    Diosuxentan is an inhibitor of ETA. Diosuxentan can be used in research for cardiovascular, renal and neuronal inflammation diseases.
    Diosuxentan
  • HY-153577
    WT-TTR inhibitor 1 23983-05-3 98.03%
    WT-TTR inhibitor 1 (Compound 21) is a wild-type Transthyretin (WT-TTR) inhibitor with 29.05% inhibition at 100 μM.
    WT-TTR inhibitor 1
  • HY-153822
    JG-23 2640819-75-4 99.64%
    JG-23 is a 4-chloro modified analog with ability to promote t-tau degradation. JG-23 exhibits good metabolic stability with a long T1/2 value (36 min) in mouse liver microsome assays.
    JG-23
  • HY-154436
    Anticonvulsant agent 2 75220-84-7 98%
    Anticonvulsant agent 2 is a potent and orally active anticonvulsant agent. Anticonvulsant agent 2 shows antiepileptic activity.
    Anticonvulsant agent 2
  • HY-15490A
    PF-670462 950980-98-0 99.24%
    PF-670462 is a selective CKI ε/δ inhibitor. PF-670462 effectively regulates the phase of the circadian rhythm.
    PF-670462
  • HY-154988
    MARK4 inhibitor 4 99.23%
    MARK4 inhibitor 4 is a MARK4 inhibitor with an IC50 of 1.49 μM. MARK4 inhibitor 4 can be used in cancer and tau lesion-related research.
    MARK4 inhibitor 4
  • HY-155126
    LZWL02003 1371564-45-2 99.38%
    LZWL02003 is an anti-neuroinflammatory agent. LZWL02003 has protective effect on MPP+-induced neuronal damage, and reduces the expression of ROS. LZWL02003 improves cognition, memory, learning, and athletic ability in a Rotenone (HY-B1756)-induced PD rat model. LZWL02003 can be used for research of neurodegenerative disease.
    LZWL02003
  • HY-155367
    mAChR antagonist 1 101491-79-6 99.59%
    mAChR antagonist 1 (compound 4a) is a mAChR antagonist with Ki values of 255 nM, 121 nM, 158 nM, and 255 nM for M1, M3, M4, and M5 subtype, respectively.
    mAChR antagonist 1
  • HY-155369
    BChE-IN-21 98%
    BChE-IN-21 is a potent BChE inhibitor with an IC50 of 0.14 ± 0.02 μM. BChE-IN-21 has the potential for alzheimer's disease research.
    BChE-IN-21
  • HY-156023
    SIRT1 activator 2 863589-52-0 99.28%
    SIRT1 activator 2 is a SIRT1 activator with an ED50 value <5 μM. SIRT1 activator 2 modulates SIRT1 deacetylase activity. SIRT1 activator 2 can be used for aging research.
    SIRT1 activator 2
  • HY-156255
    MAO-B-IN-25 2097148-47-3 99.11%
    MAO-B-IN-25 (compound 92) is a selective MAO-B inhibitor with IC50s of 0.5 nM and 240 nM for MAO-A and MAO-B, respectively.
    MAO-B-IN-25
  • HY-156532
    5-HT2C agonist-3 2104810-18-4 99.86%
    5-HT2C agonist-3 ((+)-19) is a selective 5-HT2C agonist (EC50: 24 nM, Ki: 78 nM). 5-HT2C agonist-3 has antipsychotic drug-like activity. 5-HT2C agonist-3 blocks Amphetamine-induced hyperactivity.
    5-HT2C agonist-3
  • HY-156666
    Casein kinase 1δ-IN-8 851396-73-1 98.0%
    Casein kinase 1δ-IN-8 (compound 494) is an inhibitor of Casein kinase 1δ, Casein kinase 1δ-IN-8 can be used in the study of neurodegenerative disorders such as Alzheimer's disease.
    Casein kinase 1δ-IN-8
  • HY-156667
    H4R antagonist 3 1003091-20-0
    H4R antagonist 3 (Example 8) is a histamine-4 and -1 receptor antagonist with EC50 of ≤10 mM. H4R antagonist 3 can be used for the research of prevention of inflammatory, autoimmune, allergic, and ocular diseases.
    H4R antagonist 3
  • HY-156772
    GPR88 agonist 2 2821859-71-4 99.57%
    GPR88 agonist 2 (compound 53) is a potent and brain-penetrantGPR88 agonist with an EC50 value of 14 µM in GPR88 cAMP functional assay.
    GPR88 agonist 2
  • HY-157343
    GD3 Ganglioside 62010-37-1 98%
    GD3 Ganglioside is an Apoptosis inducer and a biomarker for mouse neural stem cells. GD3 Ganglioside expresses in neural stem cells and the subventricular zone of the adult mouse brain. GD3 Ganglioside targets the mitochondrial permeability transition pore complex, induces pore opening, dissipates mitochondrial transmembrane potential, triggers Mitochondrial swelling, releases pro-apoptotic factors, and activates Caspase-9. GD3 Ganglioside is applicable to research related to glioblastoma.
    GD3 Ganglioside
  • HY-157549
    Brivoligide 1803075-42-4 98%
    Brivoligide (AYX1) is a double-stranded, unprotected, 23 base-pair oligonucleotide. Brivoligide can reduce acute post-surgical pain. Brivoligide mimics the DNA sequence normally bound by EGR1 on chromosomes.
    Brivoligide
Cat. No. Product Name / Synonyms Application Reactivity